跳至主要内容
临床试验/IRCT20200504047298N2
IRCT20200504047298N2招募中3 期

Effect of Opontia Cactus extract on improving pulmonary and clinical function in patients with Covid-19

Karaj University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Patients who have CT scan or PCR data in accordance with Covid-19
  • Patients aged 18 to 60 years
  • Patients who have not hypoxemia (oxygen saturation more than 90%)

排除标准

  • Patients who taking herbal supplements are excluded
  • Patients who were receiving mechanical ventilation or extracorporeal membrane oxygenation (ECMO) ? are excluded
  • Patients with signs of multiorgan failure at screening (Exclusion criteria included alanine aminotransferase (ALT) or aspartate aminotransferase (AST) levels greater than 5 times the upper limit of the normal range or estimated creatinine clearance of less than 50 ml per minute (by the Cockcroft–Gault formula)) are excluded

研究者

发起方
Karaj University of Medical Sciences

相似试验